March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Creation of a Macular Telangiectasia Rodent Model
Author Affiliations & Notes
  • Fakhra I. Khalid
    Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, California
  • Leah C. Byrne
    Neuroscience, UC Berkeley, Berkeley, California
  • Trevor Lee
    Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, California
  • John G. Flannery
    Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, California
  • Footnotes
    Commercial Relationships  Fakhra I. Khalid, None; Leah C. Byrne, None; Trevor Lee, None; John G. Flannery, None
  • Footnotes
    Support  NIH Grant EY016994, The Foundation for Fighting Blindness
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1640. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Fakhra I. Khalid, Leah C. Byrne, Trevor Lee, John G. Flannery; Creation of a Macular Telangiectasia Rodent Model. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1640.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To create a rodent model for Type II Macular telangiectasia (MacTel), a retinal disease characterized by vascular leakage, proliferation of blood vessels, the formation of cavities and the loss of visual acuity. The disease pathogenesis is poorly understood. We hypothesize that MacTel’s pathogenesis could involve the demise of Müller cells, the primary glial cell type in the retina.

Methods: : To test this hypothesis, we constructed a plasmid containing the KillerRed gene downstream of a viral CAG promoter. KillerRed is a fluorescent protein whose toxicity is inducible. We then packaged it into the ShH10-Y445F adeno-associated virus, a novel variant of AAV6 with high infection specificity for retinal Müller cells, and delivered it intravitreally to four mice, using ShH10 packaged with GFP as a control. After regulated sessions of irradiation with green light, we compared the KillerRed-treated eye with the control using optical coherence tomography (OCT), electroretinography (ERG), fluorescein angiography, and visualization of retinal vasculature with a lipophilic carbocyanide dye.

Results: : When we transfected the KillerRed plasmid into Müller cell culture and Hek293 T cell culture, irradiation with bright green light results in cell death after twenty minutes, compared to no cell death when transfected with GFP. KillerRed expression has been confirmed in rodents’ eyes with cryosectioning and histology. In eyes injected with KillerRed, OCT data indicates retinal thinning and structural damage, while ERG data suggests compromised light transduction.

Conclusions: : Preliminary results indicate that eliminating Muller cells in the retina results in damage to the retina’s structure and visual acuity. Further research is needed to determine effects of KillerRed on the retina’s vasculature.

Keywords: macular holes • retinal degenerations: cell biology • retinal neovascularization 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.